The
plasma levels of
celecoxib, diclofenac, and etoricoxib are reduced by
rifampicin.
The
clinical relevance of these interactions is unclear, but it seems likely that the
efficacy of these
NSAIDs will be reduced by
rifampicin. Combined use should be well monitored, and the
NSAID dosage increased if necessary.